216 related articles for article (PubMed ID: 28506782)
1. The misleading effect of serum galactomannan testing in high-risk haematology patients receiving prophylaxis with micafungin.
Vena A; Bouza E; Álvarez-Uría A; Gayoso J; Martín-Rabadán P; Cajuste F; Guinea J; Gómez Castellá J; Alonso R; Munoz P
Clin Microbiol Infect; 2017 Dec; 23(12):1000.e1-1000.e4. PubMed ID: 28506782
[TBL] [Abstract][Full Text] [Related]
2. Serum galactomannan-based early detection of invasive aspergillosis in hematology patients receiving effective antimold prophylaxis.
Duarte RF; Sánchez-Ortega I; Cuesta I; Arnan M; Patiño B; Fernández de Sevilla A; Gudiol C; Ayats J; Cuenca-Estrella M
Clin Infect Dis; 2014 Dec; 59(12):1696-702. PubMed ID: 25165088
[TBL] [Abstract][Full Text] [Related]
3. Outbreak of invasive aspergillosis in heart transplant recipients: The role of screening computed tomography scans in asymptomatic patients and universal antifungal prophylaxis.
Kabbani D; Goldraich L; Ross H; Rotstein C; Husain S
Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29125713
[TBL] [Abstract][Full Text] [Related]
4. Correlation between galactomannan antigen levels in serum and neutrophil counts in haematological patients with invasive aspergillosis.
Cordonnier C; Botterel F; Ben Amor R; Pautas C; Maury S; Kuentz M; Hicheri Y; Bastuji-Garin S; Bretagne S
Clin Microbiol Infect; 2009 Jan; 15(1):81-6. PubMed ID: 19154482
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of micafungin as an empirical therapy for invasive fungal infections in patients with hematologic disorders: a multicenter, prospective study.
Yamaguchi M; Kurokawa T; Ishiyama K; Aoki G; Ueda M; Matano S; Takami A; Yamazaki H; Sawazaki A; Yamauchi H; Yoshida T; Nakao S
Ann Hematol; 2011 Oct; 90(10):1209-17. PubMed ID: 21695388
[TBL] [Abstract][Full Text] [Related]
6. Galactomannan does not precede major signs on a pulmonary computerized tomographic scan suggestive of invasive aspergillosis in patients with hematological malignancies.
Weisser M; Rausch C; Droll A; Simcock M; Sendi P; Steffen I; Buitrago C; Sonnet S; Gratwohl A; Passweg J; Fluckiger U
Clin Infect Dis; 2005 Oct; 41(8):1143-9. PubMed ID: 16163633
[TBL] [Abstract][Full Text] [Related]
7. The effect of clinical characteristics on the performance of galactomannan and PCR for the diagnosis of invasive aspergillosis in febrile neutropenic patients.
Oz Y; Aslan M; Aksit F; Metintas S; Gunduz E
Mycoses; 2016 Feb; 59(2):86-92. PubMed ID: 26627843
[TBL] [Abstract][Full Text] [Related]
8. Primary antifungal prophylaxis with micafungin in patients with haematological malignancies: real-life data from a retrospective single-centre observational study.
Nachbaur D; Angelova O; Orth-Höller D; Ditlbacher A; Lackner M; Auberger J; Lass-Flörl C
Eur J Haematol; 2015 Mar; 94(3):258-64. PubMed ID: 25082655
[TBL] [Abstract][Full Text] [Related]
9. Correlation between high-resolution computed tomography and galactomannan antigenemia in adult hematologic patients at risk for invasive aspergillosis.
Hidalgo A; Parody R; Martino R; Sánchez F; Franquet T; Giménez A; Blancas C
Eur J Radiol; 2009 Jul; 71(1):55-60. PubMed ID: 18468830
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity of galactomannan enzyme immunoassay for diagnosing breakthrough invasive aspergillosis under antifungal prophylaxis and empirical therapy.
Hoenigl M; Seeber K; Koidl C; Buzina W; Wölfler A; Duettmann W; Wagner J; Strenger V; Krause R
Mycoses; 2013 Jul; 56(4):471-6. PubMed ID: 23432536
[TBL] [Abstract][Full Text] [Related]
11. High incidence of false-positive Aspergillus galactomannan test in multiple myeloma.
Mori Y; Nagasaki Y; Kamezaki K; Takenaka K; Iwasaki H; Harada N; Miyamoto T; Abe Y; Shimono N; Akashi K; Teshima T
Am J Hematol; 2010 Jun; 85(6):449-51. PubMed ID: 20513124
[TBL] [Abstract][Full Text] [Related]
12. Role of bi-weekly serum galactomannan screening for the diagnosis of invasive aspergillosis in haematological cancer patients.
Couchepin J; Brunel AS; Jaton K; Meylan P; Bochud PY; Lamoth F
Mycoses; 2018 Jun; 61(6):350-354. PubMed ID: 29453853
[TBL] [Abstract][Full Text] [Related]
13. Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan.
Pazos C; Pontón J; Del Palacio A
J Clin Microbiol; 2005 Jan; 43(1):299-305. PubMed ID: 15634986
[TBL] [Abstract][Full Text] [Related]
14. Combined real-time PCR and galactomannan surveillance improves diagnosis of invasive aspergillosis in high risk patients with haematological malignancies.
Rogers TR; Morton CO; Springer J; Conneally E; Heinz W; Kenny C; Frost S; Einsele H; Loeffler J
Br J Haematol; 2013 May; 161(4):517-24. PubMed ID: 23614624
[TBL] [Abstract][Full Text] [Related]
15. Surveillance of Aspergillus galactomannan antigenemia for invasive aspergillosis by enzyme-linked immunosorbent assay in neutropenic patients treated for hematological malignancies.
Ulusakarya A; Chachaty E; Vantelon JM; Youssef A; Tancrède C; Pico JL; Bourhis JH; Fenaux P; Munck JN
Hematol J; 2000; 1(2):111-6. PubMed ID: 11920178
[TBL] [Abstract][Full Text] [Related]
16. Serum galactomannan versus a combination of galactomannan and polymerase chain reaction-based Aspergillus DNA detection for early therapy of invasive aspergillosis in high-risk hematological patients: a randomized controlled trial.
Aguado JM; Vázquez L; Fernández-Ruiz M; Villaescusa T; Ruiz-Camps I; Barba P; Silva JT; Batlle M; Solano C; Gallardo D; Heras I; Polo M; Varela R; Vallejo C; Olave T; López-Jiménez J; Rovira M; Parody R; Cuenca-Estrella M; ; ; ;
Clin Infect Dis; 2015 Feb; 60(3):405-14. PubMed ID: 25336623
[TBL] [Abstract][Full Text] [Related]
17. False-positive Aspergillus galactomannan antigenaemia after haematopoietic stem cell transplantation.
Asano-Mori Y; Kanda Y; Oshima K; Kako S; Shinohara A; Nakasone H; Kaneko M; Sato H; Watanabe T; Hosoya N; Izutsu K; Asai T; Hangaishi A; Motokura T; Chiba S; Kurokawa M
J Antimicrob Chemother; 2008 Feb; 61(2):411-6. PubMed ID: 18055488
[TBL] [Abstract][Full Text] [Related]
18. Performance of the galactomannan antigen detection test in the diagnosis of invasive aspergillosis in children with cancer or undergoing haemopoietic stem cell transplantation.
Castagnola E; Furfaro E; Caviglia I; Licciardello M; Faraci M; Fioredda F; Tomà P; Bandettini R; Machetti M; Viscoli C
Clin Microbiol Infect; 2010 Aug; 16(8):1197-203. PubMed ID: 20156215
[TBL] [Abstract][Full Text] [Related]
19. False positive galactomannan results in adult hematological patients treated with piperacillin-tazobactam.
Alhambra A; Cuétara MS; Ortiz MC; Moreno JM; del Palacio A; Pontón J; del Palacio A
Rev Iberoam Micol; 2007 Jun; 24(2):106-12. PubMed ID: 17604427
[TBL] [Abstract][Full Text] [Related]
20. False-positive Aspergillus galactomannan and its kinetics in allogeneic hematopoietic stem cell transplantation.
Kimura S; Akahoshi Y; Nakano H; Harada N; Kameda K; Ugai T; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Sato M; Terasako-Saito K; Nakasone H; Kikuchi M; Yamazaki R; Kanda J; Kako S; Tanihara A; Nishida J; Kanda Y
J Infect; 2015 May; 70(5):520-40. PubMed ID: 25743584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
